SEC Filings | Celldex Therapeutics

Form	Description	Filing date	View
S-8	Securities offered to employees pursuant to employee benefit plans	Oct 9, 2009	View HTML 0001104659-09-058532.pdf 0001104659-09-058532.rtf 0001104659-09-058532.xls
3	Initial filing by director officer or owner of more than ten percent.	Oct 6, 2009	View HTML 0001104659-09-057916.pdf 0001104659-09-057916.rtf 0001104659-09-057916.xls
8-K	Report of unscheduled material events or corporate event	Oct 2, 2009	View HTML 0001104659-09-057375.pdf 0001104659-09-057375.rtf 0001104659-09-057375.xls
8-K	Report of unscheduled material events or corporate event	Sep 4, 2009	View HTML 0001157523-09-006356.pdf 0001157523-09-006356.rtf 0001157523-09-006356.xls
424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Aug 28, 2009	View HTML 0001047469-09-008048.pdf 0001047469-09-008048.rtf 0001047469-09-008048.xls
EFFECT	EFFECT	Aug 28, 2009	View HTML 9999999995-09-002409.pdf 9999999995-09-002409.rtf 9999999995-09-002409.xls
CORRESP	CORRESP	Aug 27, 2009	View HTML 0001104659-09-052164.pdf 0001104659-09-052164.rtf 0001104659-09-052164.xls
S-4/A	Pre-effective amendment to an S-4 filing	Aug 26, 2009	View HTML 0001047469-09-007997.pdf 0001047469-09-007997.rtf 0001047469-09-007997.xls
UPLOAD	UPLOAD	Aug 25, 2009	View HTML 0000000000-09-046506.pdf
S-4/A	Pre-effective amendment to an S-4 filing	Aug 18, 2009	View HTML 0001047469-09-007874.pdf 0001047469-09-007874.rtf 0001047469-09-007874.xls

Data provided by Kaleidoscope.